
|Videos|February 9, 2022
INSPIRE and IMvigor011 Trials
Jason Starr, DO, discusses the INSPIRE and IMvigor011 studies that focused on the use of ctDNA in MRD.
Advertisement
Episodes in this series
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
5 Notable FDA Approvals From the First Half of 2026
3
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
4
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
5






